SP Asset Management’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$2.55M Sell
2,770
-70
-2% -$71K 0.22% 54
2025
Q4
$3.05M Buy
2,840
+4
+0.1% +$3.83K 0.24% 58
2025
Q3
$2.16M Buy
2,836
+2
+0.1% +$1.49K 0.17% 66
2025
Q2
$2.21M Buy
2,834
+9
+0.3% +$6.99K 0.18% 66
2025
Q1
$2.33M Buy
2,825
+7
+0.2% +$5.83K 0.21% 62
2024
Q4
$2.18M Buy
2,818
+4
+0.1% +$3.31K 0.18% 68
2024
Q3
$2.49M Buy
2,814
+4
+0.1% +$3.6K 0.21% 59
2024
Q2
$2.54M Buy
2,810
+107
+4% +$85.6K 0.23% 60
2024
Q1
$2.1M Buy
2,703
+4
+0.1% +$2.85K 0.2% 62
2023
Q4
$1.57M Buy
2,699
+5
+0.2% +$2.92K 0.16% 66
2023
Q3
$1.45M Buy
2,694
+304
+13% +$157K 0.16% 67
2023
Q2
$1.12M Buy
2,390
+23
+1% +$9.65K 0.13% 70
2023
Q1
$813K Buy
2,367
+9
+0.4% +$3.04K 0.1% 76
2022
Q4
$863K Buy
2,358
+6
+0.3% +$2.13K 0.12% 74
2022
Q3
$761K Buy
2,352
+7
+0.3% +$2.22K 0.1% 75
2022
Q2
$760K Buy
2,345
+8
+0.3% +$2.4K 0.1% 77
2022
Q1
$669K Buy
2,337
+8
+0.3% +$2.06K 0.07% 88
2021
Q4
$578K Buy
2,329
+9
+0.4% +$2.28K 0.06% 88
2021
Q3
$581K Buy
2,320
+7
+0.3% +$1.73K 0.06% 86
2021
Q2
$563K Buy
2,313
+9
+0.4% +$1.81K 0.06% 82
2021
Q1
$434K Buy
2,304
+10
+0.4% +$1.96K 0.05% 83
2020
Q4
$463K Buy
2,294
+11
+0.5% +$1.64K 0.06% 79
2020
Q3
$332K Buy
2,283
+11
+0.5% +$1.7K 0.05% 77
2020
Q2
$373K Buy
2,272
+11
+0.5% +$1.69K 0.08% 67
2020
Q1
$314K Buy
2,261
+12
+0.5% +$1.65K 0.09% 64
2019
Q4
$296K Buy
2,249
+12
+0.5% +$1.39K 0.07% 68
2019
Q3
$250K Buy
+2,237
New +$249K 0.06% 71
2019
Q2
Sell
-2,212
Closed -$287K 78
2019
Q1
$287K Buy
2,212
+11
+0.5% +$1.34K 0.08% 62
2018
Q4
$254K Buy
2,201
+11
+0.5% +$1.23K 0.08% 64
2018
Q3
$235K Buy
+2,190
New +$219K 0.07% 69

Other funds holding LLY

SP Asset Management's LLY Position: Q1 2026 in Review

SP Asset Management reduced its Eli Lilly (LLY) stake by 2.5% in Q1 2026, selling an estimated $71K and leaving 2,770 shares worth $2.55M. The position accounts for 0.22% of the portfolio, ranked #54.

SP Asset Management first reported a position in LLY in Q3 2018 and has held it in 30 quarters since. The position peaked at $3.05M in Q4 2025. 4,355 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • SP Asset Management held 2,770 shares of Eli Lilly worth $2.55M as of Q1 2026.
  • SP Asset Management sold 70 Eli Lilly shares in Q1 2026, an estimated $71K.
  • Eli Lilly made up 0.22% of SP Asset Management's portfolio in Q1 2026, its #54 holding.
  • SP Asset Management first reported a position in Eli Lilly in Q3 2018 and has held it in 30 quarters since.
  • SP Asset Management's Eli Lilly position peaked at $3.05M in Q4 2025.
  • 4,355 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on SP Asset Management's 13F filing for Q1 2026, filed 7 May 2026.